Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Fluvoxamine and aggression in mental retardation.

La Malfa G, Bertelli M, Conte M.

Psychiatr Serv. 2001 Aug;52(8):1105. No abstract available.

PMID:
11474064
2.

Fluvoxamine in the treatment of corticosteroid-induced obsessive-compulsive disorder.

Oulis P, Masdrakis VG, Florakis A, Papadimitriou GN.

Clin Neuropharmacol. 2009 May-Jun;32(3):176-7. doi: 10.1097/WNF.0b013e31817c41c0. No abstract available.

PMID:
19483493
3.

Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction.

Banov MD.

J Clin Psychiatry. 1999 Dec;60(12):866-8. No abstract available.

PMID:
10665636
4.

Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.

Stahl SM.

J Clin Psychiatry. 1998 Dec;59(12):642-3. No abstract available.

5.

[Treatment of inter-specific aggression in cats with the selective serotonin reuptake inhibitor fluvoxamine. A case report].

Sprauer S.

Tierarztl Prax Ausg K Kleintiere Heimtiere. 2012;40(6):438-42. German.

PMID:
23242225
6.

Sertraline treatment of aggression in a developmentally disabled patient.

Campbell JJ 3rd, Duffy JD.

J Clin Psychiatry. 1995 Mar;56(3):123-4. No abstract available.

PMID:
7883733
7.

Fluvoxamine treatment of a child with severe PDD: a single case study.

Kauffmann C, Vance H, Pumariega AJ, Miller B.

Psychiatry. 2001 Fall;64(3):268-77.

PMID:
11708052
8.

Missing data perspectives of the fluvoxamine data set: a review.

Molenberghs G, Goetghebeur EJ, Lipsitz SR, Kenward MG, Lesaffre E, Michiels B.

Stat Med. 1999 Sep 15-30;18(17-18):2449-64. Review.

PMID:
10474152
9.

[Treatment with fluvoxamine against self-injury and aggressive behavior in autistic children].

Yokoyama H, Hirose M, Haginoya K, Munakata M, Iinuma K.

No To Hattatsu. 2002 May;34(3):249-53. Japanese.

PMID:
12030015
10.

[Effect of selective serotonin reuptake inhibitor on the chronic rumination and vomiting of a severely handicapped patient].

Saito Y, Matsui A, Kaneko K, Kimura S.

No To Hattatsu. 2003 Jul;35(4):349-52. Japanese. No abstract available.

PMID:
12875215
11.

Treatment of kleptomania with fluvoxamine.

Chong SA, Low BL.

Acta Psychiatr Scand. 1996 Apr;93(4):314-5.

PMID:
8712034
12.

Using behavioural skills training to treat aggression in adults with mild intellectual disability in a forensic setting.

Travis RW, Sturmey P.

J Appl Res Intellect Disabil. 2013 Sep;26(5):481-8. doi: 10.1111/jar.12033.

PMID:
23925970
13.

[Two cases of adult Down syndrome treated with selective serotonin re-uptake inhibitor for behavior disorders].

Hirayama T, Kobayashi T, Fujita T, Fujino O.

No To Hattatsu. 2004 Sep;36(5):391-4. Japanese.

PMID:
15461027
14.

Fluvoxamine in civilians with posttraumatic stress disorder.

Davidson JR, Weisler RH, Malik M, Tupler LA.

J Clin Psychopharmacol. 1998 Feb;18(1):93-5. No abstract available.

PMID:
9472854
15.

Fluvoxamine improved cognitive impairments in a patient with schizophrenia.

Niitsu T, Shirayama Y, Fujisaki M, Hashimoto K, Iyo M.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1345-6. doi: 10.1016/j.pnpbp.2010.06.007. No abstract available.

PMID:
20600473
16.

The difference between the formal and the functional dose: the case of the patient on thioridazine and fluvoxamine.

Preskorn SH.

J Psychiatr Pract. 2005 May;11(3):192-6. No abstract available.

PMID:
15920392
17.
18.

Fluvoxamine treatment of a Japanese patient with koro.

Nakaya M.

J Clin Psychiatry. 2002 Dec;63(12):1182-3. No abstract available.

PMID:
12530418
19.

Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia.

Iyo M, Shirayama Y, Watanabe H, Fujisaki M, Miyatake R, Fukami G, Shiina A, Nakazato M, Shiraishi T, Ookami T, Hashimoto K.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):1072-3. doi: 10.1016/j.pnpbp.2008.01.005. No abstract available.

PMID:
18262707
20.

A subtype of auditory verbal hallucinations responds to fluvoxamine.

Stephane M, Polis I, Barton SN.

J Neuropsychiatry Clin Neurosci. 2001 Summer;13(3):425-7. No abstract available.

PMID:
11514657
Items per page

Supplemental Content

Support Center